405 related articles for article (PubMed ID: 18080224)
21. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of infliximab in steroid-dependent ulcerative colitis patients.
Gavalas E; Kountouras J; Stergiopoulos C; Zavos C; Gisakis D; Nikolaidis N; Giouleme O; Chatzopoulos D; Kapetanakis N
Hepatogastroenterology; 2007 Jun; 54(76):1074-9. PubMed ID: 17629042
[TBL] [Abstract][Full Text] [Related]
23. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
Habal FM; Greenberg GR
Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
[TBL] [Abstract][Full Text] [Related]
24. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study.
Henker J; Müller S; Laass MW; Schreiner A; Schulze J
Z Gastroenterol; 2008 Sep; 46(9):874-5. PubMed ID: 18810672
[TBL] [Abstract][Full Text] [Related]
25. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
Sandborn WJ; Regula J; Feagan BG; Belousova E; Jojic N; Lukas M; Yacyshyn B; Krzeski P; Yeh CH; Messer CA; Hanauer SB
Gastroenterology; 2009 Dec; 137(6):1934-43.e1-3. PubMed ID: 19766640
[TBL] [Abstract][Full Text] [Related]
26. Early onset steroid-dependent ulcerative colitis is a predictor of azathioprine response: a longitudinal 12-month follow-up study.
Chebli LA; Felga GG; Chaves LD; Pimentel FF; Guerra DM; Gaburri PD; Zanini A; Chebli JM
Med Sci Monit; 2010 Feb; 16(2):PI1-6. PubMed ID: 20110928
[TBL] [Abstract][Full Text] [Related]
27. Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment.
Bresci G; Parisi G; Capria A
Colorectal Dis; 2008 Oct; 10(8):814-7. PubMed ID: 18834420
[TBL] [Abstract][Full Text] [Related]
28. Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis.
Fernández-Bañares F; Bertrán X; Esteve-Comas M; Cabré E; Menacho M; Humbert P; Planas R; Gassull MA
Am J Gastroenterol; 1996 Dec; 91(12):2498-9. PubMed ID: 8946973
[TBL] [Abstract][Full Text] [Related]
29. Infliximab in the treatment of steroid-dependent ulcerative colitis.
Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236
[TBL] [Abstract][Full Text] [Related]
30. Are patients with inflammatory bowel disease receiving optimal care?
Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
[TBL] [Abstract][Full Text] [Related]
31. Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
Hanauer SB
Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():37-40. PubMed ID: 16961743
[TBL] [Abstract][Full Text] [Related]
32. Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.
Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
J Gastroenterol Hepatol; 2008 Nov; 23(11):1678-82. PubMed ID: 18823440
[TBL] [Abstract][Full Text] [Related]
33. Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: a randomized, double-blind trial.
Bossa F; Fiorella S; Caruso N; Accadia L; Napolitano G; Valvano MR; Andriulli A; Annese V
Am J Gastroenterol; 2007 Mar; 102(3):601-8. PubMed ID: 17156148
[TBL] [Abstract][Full Text] [Related]
34. Tacrolimus therapy as an alternative to thiopurines for maintaining remission in patients with refractory ulcerative colitis.
Yamamoto S; Nakase H; Matsuura M; Masuda S; Inui K; Chiba T
J Clin Gastroenterol; 2011 Jul; 45(6):526-30. PubMed ID: 21336140
[TBL] [Abstract][Full Text] [Related]
35. Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis.
Wenzl HH; Petritsch W; Aichbichler BW; Hinterleitner TA; Fleischmann G; Krejs GJ
Z Gastroenterol; 1998 Apr; 36(4):287-93. PubMed ID: 9612926
[TBL] [Abstract][Full Text] [Related]
36. Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
Hanauer S; Good LI; Goodman MW; Pizinger RJ; Strum WB; Lyss C; Haber G; Williams CN; Robinson M
Am J Gastroenterol; 2000 Jul; 95(7):1749-54. PubMed ID: 10925979
[TBL] [Abstract][Full Text] [Related]
37. Induction and maintenance of clinical remission by interferon-beta in patients with steroid-refractory active ulcerative colitis-an open long-term pilot trial.
Musch E; Andus T; Malek M
Aliment Pharmacol Ther; 2002 Jul; 16(7):1233-9. PubMed ID: 12144572
[TBL] [Abstract][Full Text] [Related]
38. Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.
D'Haens G; Hommes D; Engels L; Baert F; van der Waaij L; Connor P; Ramage J; Dewit O; Palmen M; Stephenson D; Joseph R
Aliment Pharmacol Ther; 2006 Oct; 24(7):1087-97. PubMed ID: 16984503
[TBL] [Abstract][Full Text] [Related]
39. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.
Moayyeri A; Daryani NE; Bahrami H; Haghpanah B; Nayyer-Habibi A; Sadatsafavi M
J Gastroenterol Hepatol; 2005 Mar; 20(3):366-70. PubMed ID: 15740478
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
Cohen RD; Woseth DM; Thisted RA; Hanauer SB
Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
